Bellicum Pharmaceuticals Inc 's

• BLCM's Stock Performance relative to its Competitors

Iterum Therapeutics Plc Share Performance +292.67% 30 Days

Iterum Therapeutics Plc Profile Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market. More about Iterum Therapeutics Plc's Market Share

Nkarta Inc Share Performance -16.92% This Quarter

Nkarta Inc Profile Nkarta Inc is a biotechnology company with a business model centered on developing and commercializing engineered natural killer (NK) cell therapies for cancer patients. By utilizing proprietary technologies and expertise in genetic engineering, the company aims to enhance the therapeutic potential of NK cells and address unmet needs in the field of oncology. Nkarta Inc focuses on research, development, and production of these advanced cell therapies, collaborating with partners and regulators to bring innovative treatments to patients. More about Nkarta Inc 's Market Share

Nurix Therapeutics Inc Share Performance -3.38% Over The Past 5 Days

Nurix Therapeutics Inc Profile Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels. More about Nurix Therapeutics Inc 's Market Share

Nuvalent Inc Share Performance +48.63% One Year

Nuvalent Inc Profile Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise. More about Nuvalent Inc 's Market Share

Novavax inc Share Performance +36.57% 30 Days

Novavax inc Profile Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market. More about Novavax inc 's Market Share

Sources: Bellicum Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 4:59 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bellicum Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.